Albertsons Companies (ACI) 10-Q 15 Oct 24 2024 Q2 Quarterly report Financial data

COVER PAGE

COVER PAGE - shares	6 Months Ended
	Sep. 07, 2024	Oct. 11, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 07, 2024
Document Transition Report	false
Entity File Number	001-39350
Entity Registrant Name	Albertsons Companies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4376911
Entity Address, Address Line One	250 Parkcenter Blvd.
Entity Address, City or Town	Boise
Entity Address, State or Province	ID
Entity Address, Postal Zip Code	83706
City Area Code	208
Local Phone Number	395-6200
Title of 12(b) Security	Class A common stock, $0.01 par value
Trading Symbol	ACI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		579,348,079
Entity Central Index Key	0001646972
Current Fiscal Year End	--02-22
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 07, 2024	Feb. 24, 2024
Current assets
Cash and cash equivalents	$ 280	$ 188.7
Receivables, net	897.6	724.4
Inventories, net	5,042.7	4,945.2
Other current assets	426.3	429.2
Total current assets	6,646.6	6,287.5
Property and equipment, net	9,551.4	9,570.3
Operating lease right-of-use assets	6,022.6	5,981.6
Intangible assets, net	2,377.9	2,434.5
Goodwill	1,201	1,201
Other assets	728.9	746.2
TOTAL ASSETS	26,528.4	26,221.1
Current liabilities
Accounts payable	4,221.9	4,218.2
Accrued salaries and wages	1,352.2	1,302.6
Current maturities of long-term debt and finance lease obligations	129.1	285.2
Current maturities of operating lease obligations	679.3	677.6
Other current liabilities	1,039.9	974.1
Total current liabilities	7,422.4	7,457.7
Long-term debt and finance lease obligations	7,779.3	7,783.4
Long-term operating lease obligations	5,615.1	5,493.2
Deferred income taxes	727.5	807.6
Other long-term liabilities	1,963.8	1,931.7
Commitments and contingencies
STOCKHOLDERS' EQUITY
Additional paid-in capital	2,152.3	2,129.6
Treasury stock, at cost, 18,404,201 and 18,397,745 shares held as of September 7, 2024 and February 24, 2024, respectively	(304.2)	(304.2)
Accumulated other comprehensive income	92.6	88
Retained earnings	1,073.6	828.2
Total stockholders' equity	3,020.3	2,747.5
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	26,528.4	26,221.1
Class A common stock
STOCKHOLDERS' EQUITY
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized, 597,711,686 and 594,445,268 shares issued as of September 7, 2024 and February 24, 2024, respectively	$ 6	$ 5.9

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 07, 2024	Feb. 24, 2024
Treasury stock, at cost (in shares)	18,404,201	18,397,745
Class A common stock
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock shares issued (in shares)	597,711,686	594,445,268

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Income Statement [Abstract]
Net sales and other revenue	$ 18,551.5	$ 18,290.7	$ 42,816.9	$ 42,340.9
Cost of sales	13,430.2	13,249.2	30,956.7	30,636.7
Gross margin	5,121.3	5,041.5	11,860.2	11,704.2
Selling and administrative expenses	4,785.4	4,595.5	11,059.4	10,608.4
Loss (gain) on property dispositions and impairment losses, net	43.9	(8.4)	49.2	19.2
Operating income	292	454.4	751.6	1,076.6
Interest expense, net	103.6	111.9	249.3	266.8
Other expense (income), net	1.9	8.1	5.9	(7.9)
Income before income taxes	186.5	334.4	496.4	817.7
Income tax expense	41	67.5	110.2	133.6
Net income	145.5	266.9	386.2	684.1
Other comprehensive income (loss), net of tax
Recognition of pension gain (loss)	2.9	(1.9)	1.9	(2.5)
Other	3	0.4	2.7	2.1
Other comprehensive income (loss)	5.9	(1.5)	4.6	(0.4)
Comprehensive income	$ 151.4	$ 265.4	$ 390.8	$ 683.7
Net income per Class A common share
Basic net income per Class A common share (in dollars per share)	$ 0.25	$ 0.46	$ 0.67	$ 1.19
Diluted net income per Class A common share (in dollars per share)	$ 0.25	$ 0.46	$ 0.66	$ 1.18
Weighted average Class A common shares outstanding (in millions)
Basic (in shares)	580.1	576	579.5	574.7
Diluted (in shares)	583.2	581.9	582.4	580.3

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023
Cash flows from operating activities:
Net income	$ 386.2	$ 684.1
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on property dispositions and impairment losses, net	49.2	19.2
Depreciation and amortization	973.9	945.2
Operating lease right-of-use assets amortization	364.3	357
LIFO expense	19.4	60.2
Deferred income tax	(86.7)	(85.8)
Contributions to pension and post-retirement benefit plans, net of expense (income)	(29.3)	(12.1)
Deferred financing costs	8.6	8.4
Equity-based compensation expense	66.2	57.2
Other operating activities	17	(12.3)
Changes in operating assets and liabilities:
Receivables, net	(174)	(21.3)
Inventories, net	(116.9)	(326.6)
Accounts payable, accrued salaries and wages and other accrued liabilities	88.5	35.1
Operating lease liabilities	(280.6)	(274.7)
Self-insurance assets and liabilities	21.2	40.3
Other operating assets and liabilities	67.1	(126)
Net cash provided by operating activities	1,374.1	1,347.9
Cash flows from investing activities:
Payments for property, equipment and intangibles, including lease buyouts	(952.3)	(1,084.3)
Proceeds from sale of assets	19.8	195.1
Other investing activities	7.2	(0.9)
Net cash used in investing activities	(925.3)	(890.1)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, including ABL facility	50	50
Payments on long-term borrowings, including ABL facility	(200.4)	(500.5)
Payments of obligations under finance leases	(26.9)	(29.1)
Dividends paid on common stock	(139)	(138)
Dividends paid on convertible preferred stock	0	(0.8)
Employee tax withholding on vesting of restricted stock units	(41.5)	(35.1)
Other financing activities	0	2.4
Net cash used in financing activities	(357.8)	(651.1)
Net increase (decrease) in cash and cash equivalents and restricted cash	91	(193.3)
Cash and cash equivalents and restricted cash at beginning of period	193.2	463.8
Cash and cash equivalents and restricted cash at end of period	$ 284.2	$ 270.5

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock Class A Common Stock	Additional paid-in capital	Treasury Stock	Accumulated other comprehensive income	Retained earnings
Beginning balance (in shares) at Feb. 25, 2023		590,968,600
Beginning balance at Feb. 25, 2023	$ 1,610.7	$ 5.9	$ 2,072.7	$ (352.2)	$ 69.3	$ (185)
Beginning balance (in shares) at Feb. 25, 2023				21,300,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	27.7		27.7
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)		3,059,905
Shares issued and employee tax withholding on vesting of restricted stock units	(33.1)		(33.1)
Convertible preferred stock conversions (in shares)				(2,903,200)
Convertible preferred stock conversions	45.7			$ 48		(2.3)
Cash dividends declared on common stock	(69)					(69)
Dividends accrued on convertible preferred stock	(0.3)					(0.3)
Net income	417.2					417.2
Other comprehensive income (loss), net of tax	1.1				1.1
Other activity	0		1			(1)
Ending balance (in shares) at Jun. 17, 2023		594,028,505
Ending balance at Jun. 17, 2023	2,000	$ 5.9	2,068.3	$ (304.2)	70.4	159.6
Ending balance (in shares) at Jun. 17, 2023				18,397,745
Beginning balance (in shares) at Feb. 25, 2023		590,968,600
Beginning balance at Feb. 25, 2023	1,610.7	$ 5.9	2,072.7	$ (352.2)	69.3	(185)
Beginning balance (in shares) at Feb. 25, 2023				21,300,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	684.1
Ending balance (in shares) at Sep. 09, 2023		594,227,946
Ending balance at Sep. 09, 2023	2,216.6	$ 5.9	2,089.6	$ (304.2)	68.9	356.4
Ending balance (in shares) at Sep. 09, 2023				18,397,745
Beginning balance (in shares) at Jun. 17, 2023		594,028,505
Beginning balance at Jun. 17, 2023	2,000	$ 5.9	2,068.3	$ (304.2)	70.4	159.6
Beginning balance (in shares) at Jun. 17, 2023				18,397,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	22.2		22.2
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)		199,441
Shares issued and employee tax withholding on vesting of restricted stock units	(2)		(2)
Cash dividends declared on common stock	(69)					(69)
Net income	266.9					266.9
Other comprehensive income (loss), net of tax	(1.5)				(1.5)
Other activity	0		1.1			(1.1)
Ending balance (in shares) at Sep. 09, 2023		594,227,946
Ending balance at Sep. 09, 2023	2,216.6	$ 5.9	2,089.6	$ (304.2)	68.9	356.4
Ending balance (in shares) at Sep. 09, 2023				18,397,745
Beginning balance (in shares) at Feb. 24, 2024		594,445,268
Beginning balance at Feb. 24, 2024	$ 2,747.5	$ 5.9	2,129.6	$ (304.2)	88	828.2
Beginning balance (in shares) at Feb. 24, 2024	18,397,745			18,397,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	$ 34.4		34.4
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)		3,048,974
Shares issued and employee tax withholding on vesting of restricted stock units	(38.5)	$ 0.1	(38.6)
Cash dividends declared on common stock	(69.5)					(69.5)
Net income	240.7					240.7
Other comprehensive income (loss), net of tax	(1.3)				(1.3)
Other activity (in shares)				6,456
Other activity	(0.2)		0.8			(1)
Ending balance (in shares) at Jun. 15, 2024		597,494,242
Ending balance at Jun. 15, 2024	2,913.1	$ 6	2,126.2	$ (304.2)	86.7	998.4
Ending balance (in shares) at Jun. 15, 2024				18,404,201
Beginning balance (in shares) at Feb. 24, 2024		594,445,268
Beginning balance at Feb. 24, 2024	$ 2,747.5	$ 5.9	2,129.6	$ (304.2)	88	828.2
Beginning balance (in shares) at Feb. 24, 2024	18,397,745			18,397,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 386.2
Ending balance (in shares) at Sep. 07, 2024		597,711,686
Ending balance at Sep. 07, 2024	$ 3,020.3	$ 6	2,152.3	$ (304.2)	92.6	1,073.6
Ending balance (in shares) at Sep. 07, 2024	18,404,201			18,404,201
Beginning balance (in shares) at Jun. 15, 2024		597,494,242
Beginning balance at Jun. 15, 2024	$ 2,913.1	$ 6	2,126.2	$ (304.2)	86.7	998.4
Beginning balance (in shares) at Jun. 15, 2024				18,404,201
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	27.9		27.9
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)		217,444
Shares issued and employee tax withholding on vesting of restricted stock units	(2.9)		(2.9)
Cash dividends declared on common stock	(69.5)					(69.5)
Net income	145.5					145.5
Other comprehensive income (loss), net of tax	5.9				5.9
Other activity	0.3		1.1			(0.8)
Ending balance (in shares) at Sep. 07, 2024		597,711,686
Ending balance at Sep. 07, 2024	$ 3,020.3	$ 6	$ 2,152.3	$ (304.2)	$ 92.6	$ 1,073.6
Ending balance (in shares) at Sep. 07, 2024	18,404,201			18,404,201

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		4 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Jun. 15, 2024	Jun. 17, 2023
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.12	$ 0.12	$ 0.12	$ 0.12

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 24, 2024 is derived from the Company's annual audited Consolidated Financial Statements, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K for the fiscal year ended February 24, 2024, filed with the Securities and Exchange Commission (the "SEC") on April 22, 2024. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company' s results of operations are for the 12 and 28 weeks ended September 7, 2024 and September 9, 2023. Significant Accounting Policies Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to surety bonds. The Company had $4.2 million and $4.5 million of restricted cash as of September 7, 2024 and February 24, 2024, respectively. Inventories, net: Substantially all of the Company's inventories consist of finished goods valued at the lower of cost or market and net of vendor allowances. The Company primarily uses the retail inventory or cost method to determine inventory cost before application of any last-in, first-out ("LIFO") adjustment. Interim LIFO inventory costs are based on management's estimates of expected year-end inventory levels and inflation rates. The Company recorded LIFO expense of $4.8 million and $26.2 million for the 12 weeks ended September 7, 2024 and September 9, 2023, respectively, and $19.4 million and $60.2 million for the 28 weeks ended September 7, 2024 and September 9, 2023, respectively. Equity method investments: The Company's equity method investments previously included an equity interest in Mexico Foods Parent LLC and La Fabrica Parent LLC ("El Rancho"), a Texas-based specialty grocer. During the first quarter of fiscal 2023, El Rancho exercised its contractual option to repurchase the Company's 45% ownership interest in El Rancho and the Company received proceeds of $166.1 million. As a result, the Company realized a gain of $10.5 million during the first quarter of fiscal 2023, included in Other expense (income), net. Convertible Common Stock and Preferred Stock : The Company's certificate of incorporation authorizes 150,000,000 shares of Class A-1 convertible common stock, par value $0.01 per share, and 100,000,000 shares of preferred stock, par value $0.01 per share, of which 1,750,000 shares of preferred stock are designated Series A convertible preferred stock ("Series A preferred stock") and 1,410,000 shares of preferred stock are designated Series A-1 convertible preferred stock ("Series A-1 preferred stock" and together with the Series A preferred stock, the "Convertible Preferred Stock"). As of September 7, 2024 and February 24, 2024, no shares of Class A-1 convertible common stock and no shares of preferred stock are issued or outstanding. Income taxes: Income tax expense was $41.0 million, representing a 22.0% effective tax rate, for the 12 weeks ended September 7, 2024. The Company's effective tax rate for the 12 weeks ended September 7, 2024 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits. Income tax expense was $67.5 million, representing a 20.2% effective tax rate, for the 12 weeks ended September 9, 2023. The Company's effective tax rate for the 12 weeks ended September 9, 2023 differs from the federal income tax statutory rate of 21% primarily due to the recognition of discrete state income tax benefits related to audit settlements and favorable legislation during the 12 weeks ended September 9, 2023. Income tax expense was $110.2 million, representing a 22.2% effective tax rate, for the 28 weeks ended September 7, 2024. The Company's effective tax rate for the 28 weeks ended September 7, 2024 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits and the reduction of a reserve for an uncertain tax position due to the expiration of a state statute. Income tax expense was $133.6 million, representing a 16.3% effective tax rate, for the 28 weeks ended September 9, 2023. The Company's effective tax rate for the 28 weeks ended September 9, 2023 differs from the federal income tax statutory rate of 21% primarily due to the reduction of a reserve of $49.7 million for an uncertain tax position due to the expiration of a foreign statute during the first quarter of fiscal 2023, as well as discrete benefits recognized for state income taxes. Segments: The Company and its subsidiaries offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company's operating divisions are geographically based, have similar economic characteristics and similar expected long-term financial performance. The Company's operating segments and reporting units are its 12 operating divisions, which are reported in one reportable segment. Each reporting unit constitutes a business for which discrete financial information is available and for which management regularly reviews the operating results. Across all operating segments, the Company operates primarily one store format. Each division offers through its stores and digital channels the same general mix of products with similar pricing to similar categories of customers, has similar distribution methods, operates in similar regulatory environments and purchases merchandise from similar or the same vendors. Revenue recognition: Revenues from the retail sale of products are recognized at the point of sale or delivery to the customer, net of returns and sales tax. Pharmacy sales are recorded upon the customer receiving the prescription. Third-party receivables from pharmacy sales were $490.4 million and $376.1 million as of September 7, 2024 and February 24, 2024, respectively, and are recorded in Receivables, net. For digital related sales, which primarily include home delivery and Drive Up & Go curbside pickup, revenues are recognized upon either pickup in store or delivery to the customer and may include revenue for separately charged delivery services. The Company records a contract liability when rewards are earned by customers in connection with the Company's loyalty programs. As rewards are redeemed or expire, the Company reduces the contract liability and recognizes revenue. The contract liability balance was immaterial as of September 7, 2024 and February 24, 2024. The Company records a contract liability when it sells its own proprietary gift cards. The Company records a sale when the customer redeems the gift card. The Company's gift cards do not expire. The Company reduces the contract liability and records revenue for the unused portion of gift cards in proportion to its customers' pattern of redemption, which the Company determined to be the historical redemption rate. The Company's contract liability related to gift cards was $97.3 million and $111.4 million as of September 7, 2024 and February 24, 2024, respectively. Disaggregated Revenues The following table represents Net sales and other revenue by product type (dollars in millions): 12 weeks ended 28 weeks ended September 7, September 9, September 7, September 9, Amount (1) % of Total Amount (1) % of Total Amount (1) % of Total Amount (1) % of Total Non-perishables (2) $ 9,265.0 49.9 % $ 9,236.9 50.5 % $ 21,319.0 49.8 % $ 21,323.7 50.4 % Fresh (3) 5,917.4 31.9 5,919.4 32.4 13,822.3 32.3 13,808.7 32.6 Pharmacy 2,132.0 11.5 1,741.0 9.5 4,754.8 11.1 4,041.1 9.5 Fuel 951.3 5.2 1,126.8 6.1 2,272.2 5.3 2,527.2 6.0 Other (4) 285.8 1.5 266.6 1.5 648.6 1.5 640.2 1.5 Net sales and other revenue $ 18,551.5 100.0 % $ 18,290.7 100.0 % $ 42,816.9 100.0 % $ 42,340.9 100.0 % (1) Digital related sales are included in the categories to which the revenue pertains. (2) Consists primarily of general merchandise, grocery, dairy and frozen foods. (3) Consists primarily of produce, meat, deli and prepared foods, bakery, floral and seafood. (4) Consists primarily of wholesale revenue to third parties, commissions, rental income and other miscellaneous revenue. Recently issued accounting standards : In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07, " Segment Reporting Topic (280): Improvements to Reportable Segment Disclosure. " The ASU improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, " Income Taxes (Topic 740): Improvements to Income Tax Disclosures. " The ASU enhances the transparency and decision usefulness of income tax disclosures and is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.

MERGER AGREEMENT

MERGER AGREEMENT	6 Months Ended
	Sep. 07, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
MERGER AGREEMENT	MERGER AGREEMENT On October 13, 2022, the Company, The Kroger Co. ("Parent") and Kettle Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), pursuant to which Merger Sub will be merged with and into the Company (the "Merger"), with the Company surviving the Merger as the surviving corporation and a direct, wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, each share of Class A common stock issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time"), shall be converted automatically at the Effective Time into the right to receive from Parent $34.10 per share in cash, without interest. The $34.10 per share consideration to be paid by Parent would be reduced by the special cash dividend of $6.85 per share of Class A common stock (the "Special Dividend"), which was declared on October 13, 2022 and paid on January 20, 2023. At the Effective Time, each outstanding equity award denominated in shares of Class A common stock will be converted into a corresponding award with respect to shares of Parent common stock (the "Converted Awards"). The Converted Awards will remain outstanding and subject to the same terms and conditions (including vesting and forfeiture terms) as were applied to the corresponding Company equity award immediately prior to the Effective Time; provided that any Company equity award with a performance-based vesting condition will have such vesting condition deemed satisfied at (i) the greater of target performance and actual performance (for such awards subject to an open performance period at the Effective Time) and (ii) target performance (for such awards subject to a performance period that begins after the Effective Time). For purposes of the conversion described above, the number of shares of Parent common stock subject to a Converted Award will be based upon the number of shares of Class A common stock subject to such Company equity award immediately prior to the Effective Time multiplied by an exchange ratio equal to (i) $34.10 less the Special Dividend, divided by (ii) the average closing price of shares of Parent common stock for five In connection with obtaining the requisite regulatory clearance necessary to consummate the Merger, the Company and Parent expect to make divestitures of stores owned by the Company and Parent to a third party. As described in the Merger Agreement and subject to the outcome of the divestiture process and negotiations with applicable government authorities, the Company was prepared to establish a Company subsidiary ("SpinCo") as part of this process. If utilized, the common stock or interests in SpinCo would be distributed to Company stockholders no later than the closing of the Merger (the "Closing") and SpinCo would operate as a standalone public company, or the equity of SpinCo would be contributed to a trust for later distribution to Company stockholders. As described in more detail below, on September 8, 2023, the Company and Kroger announced that they entered into a comprehensive divestiture plan with C&S Wholesale Grocers, LLC ("C&S"). As a result of the comprehensive divestiture plan announced with C&S, Kroger has exercised its right under the Merger Agreement to sell what would have been the SpinCo business to C&S. Consequently, the creation of SpinCo and spin-off previously contemplated by the Company and Kroger is no longer a requirement under the Merger Agreement and will no longer be pursued by the Company and Kroger. On September 8, 2023, the Company and Kroger announced that the parties had entered into a definitive agreement, dated September 8, 2023, with C&S for the sale of select stores, banners, distribution centers, offices and private label brands to C&S. On April 22, 2024, the Company and Kroger announced they had amended the definitive agreement with C&S. The amended package modifies and builds on the initial divestiture package (collectively, the "Divestiture Assets"). The Divestiture Assets will be divested by Kroger following the Closing. The definitive agreement has customary representations and warranties and covenants of a transaction of its type. The divestiture to C&S is subject to fulfillment of customary closing conditions, including clearance by the United States Federal Trade Commission ("FTC") and the completion of the proposed Merger. In accordance with the Merger Agreement, the Company has extended the original outside date of January 13, 2024 to October 9, 2024 (the "Outside Date"). The Parent will be obligated to pay a termination fee of $600 million to the Company if the Merger Agreement is terminated by either party in connection with the occurrence of the Outside Date, and, at the time of such termination, all closing conditions other than regulatory approval have been satisfied. As of the time of filing this Quarterly Report on Form 10-Q, neither the Company nor Parent has provided a notice of termination with respect to the Merger Agreement. On February 26, 2024, the FTC instituted an administrative proceeding to prohibit the Merger. On the same day, the FTC (joined by nine states) filed suit in the United States District Court for the District of Oregon, requesting a preliminary injunction to enjoin the Merger (the "Federal Action"). On January 15, 2024 and February 14, 2024, the attorneys general of States of Washington and Colorado, respectively, filed suit in their respective state courts, also seeking to enjoin the Merger. In the Federal Action, the Company and Parent have stipulated to a temporary restraining order that prevents the Merger from closing until 11:59 PM Eastern Time on the fifth business day after the court rules on the FTC's motion for a preliminary injunction or until after the date set by the court, whichever is later. The FTC administrative proceeding and the preliminary injunction hearing in the Federal Action have concluded and the Company awaits a decision. A trial on the State of Washington's request for a permanent injunction has concluded and the Company awaits a decision. In conjunction with the State of Washington's suit, the Company and Parent have committed that they will not close the Merger until five days after that court rules (so

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Sep. 07, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The accounting guidance for fair value established a framework for measuring fair value and established a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability at the measurement date. The three levels are defined as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs in which little or no market activity exists, requiring an entity to develop its own assumptions that market participants would use to value the asset or liability. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following table presents certain assets which were measured at fair value on a recurring basis as of September 7, 2024 (in millions): Fair Value Measurements Total Quoted prices in active markets Significant Significant Assets: Short-term investments (1) $ 17.2 $ 6.2 $ 11.0 $ — Non-current investments (2) 109.6 6.7 102.9 — Total $ 126.8 $ 12.9 $ 113.9 $ — Liabilities: Derivative contracts (3) $ 1.5 $ — $ 1.5 $ — Total $ 1.5 $ — $ 1.5 $ — (1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets. (2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets. (3) Primarily relates to energy derivative contracts. Included in Other current liabilities. The following table presents certain assets which were measured at fair value on a recurring basis as of February 24, 2024 (in millions): Fair Value Measurements Total Quoted prices in active markets Significant Significant Assets: Short-term investments (1) $ 23.3 $ 5.3 $ 18.0 $ — Non-current investments (2) 107.3 6.4 100.9 — Derivative contracts (3) 1.5 — 1.5 — Total $ 132.1 $ 11.7 $ 120.4 $ — Liabilities: Derivative contracts (3) $ 0.8 $ — $ 0.8 $ — Total $ 0.8 $ — $ 0.8 $ — (1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets. (2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets. (3) Primarily relates to energy derivative contracts. Included in Other assets or Other current liabilities. The Company records cash and cash equivalents, restricted cash, accounts receivable and accounts payable at cost. The recorded values of these financial instruments approximate fair value based on their short-term nature. The estimated fair value of the Company's debt, including current maturities, was based on Level 2 inputs, being market quotes or values for similar instruments, and interest rates currently available to the Company for the issuance of debt with similar terms and remaining maturities as a discount rate for the remaining principal payments. As of September 7, 2024, the fair value of total debt was $7,411.9 million compared to the carrying value of $7,533.8 million, excluding debt discounts and deferred financing costs. As of February 24, 2024, the fair value of total debt was $7,457.2 million compared to the carrying value of $7,684.2 million, excluding debt discounts and deferred financing costs. Assets Measured at Fair Value on a Non-Recurring Basis The Company measures certain assets at fair value on a non-recurring basis, including long-lived assets and goodwill, which are evaluated for impairment. Long-lived assets include store-related assets such as property and equipment, operating lease assets and certain intangible assets. The inputs used to determine the fair value of long-lived assets and a reporting unit are considered Level 3 measurements due to their subjective nature. During the 12 weeks ended September 7, 2024, the Company recorded impairment losses of $39.8 million, primarily related to equipment from the closing of our micro-fulfillment centers and $13.5 million of retail store impairment losses. The impairment losses are included as a component of Loss (gain) on property dispositions and impairment losses, net.

LONG-TERM DEBT AND FINANCE LEAS

LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS	6 Months Ended
	Sep. 07, 2024
Debt Disclosure [Abstract]
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS	LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS The Company's long-term debt and finance lease obligations as of September 7, 2024 and February 24, 2024, net of unamortized debt discounts of $30.8 million and $33.3 million, respectively, and deferred financing costs of $36.8 million and $42.7 million, respectively, consisted of the following (in millions): September 7, February 24, Senior Unsecured Notes due 2026 to 2030, interest rate range of 3.25% to 7.50% $ 6,512.0 $ 6,506.4 New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% 482.6 480.1 Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% 375.7 375.4 ABL Facility 50.0 200.0 Other financing obligations 29.6 29.9 Mortgage notes payable, secured 16.3 16.4 Finance lease obligations 442.2 460.4 Total debt 7,908.4 8,068.6 Less current maturities (129.1) (285.2) Long-term portion $ 7,779.3 $ 7,783.4 ABL Facility As of September 7, 2024, there was $50.0 million outstanding under the ABL Facility as the Company repaid $200.0 million and borrowed $50.0 million during the 28 weeks ended September 7, 2024, and letters of credit ("LOC") issued under the LOC sub-facility was $41.7 million. As of February 24, 2024, there was $200.0 million outstanding under the ABL Facility and LOC issued under the LOC sub-facility was $48.3 million.

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	6 Months Ended
	Sep. 07, 2024
Retirement Benefits [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS Pension and Other Post-Retirement Benefits The following table provides the components of net pension and post-retirement expense (income) (in millions): 12 weeks ended Pension Other post-retirement benefits September 7, September 9, September 7, September 9, Estimated return on plan assets $ (21.1) $ (22.7) $ — $ — Service cost 3.9 4.0 — — Interest cost 19.3 19.3 0.1 0.1 Amortization of prior service cost 0.1 0.1 — — Amortization of net actuarial gain (0.8) (2.4) (0.2) (0.2) Settlement loss 4.7 — — — Expense (income), net $ 6.1 $ (1.7) $ (0.1) $ (0.1) 28 weeks ended Pension Other post-retirement benefits September 7, September 9, September 7, September 9, Estimated return on plan assets $ (49.2) $ (53.0) $ — $ — Service cost 9.0 9.3 — — Interest cost 45.2 45.0 0.3 0.3 Amortization of prior service cost 0.2 0.2 — — Amortization of net actuarial gain (2.0) (3.0) (0.4) (0.5) Settlement loss 4.7 — — — Expense (income), net $ 7.9 $ (1.5) $ (0.1) $ (0.2) The Company contributed $24.4 million and $37.1 million to its defined pension plans and post-retirement benefit plans during the 12 and 28 weeks ended September 7, 2024, respectively. For the 12 and 28 weeks ended September 9, 2023, the company contributed $3.9 million and $10.4 million, respectively. At the Company's discretion, additional funds may be contributed to the defined benefit pension plans that are determined to be beneficial to the Company. The Company currently anticipates contributing an additional $50.3 million to these plans for the remainder of fiscal 2024.

COMMITMENTS AND CONTINGENCIES A

COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS	6 Months Ended
	Sep. 07, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS	COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS Guarantees Lease Guarantees: The Company may have liability under certain operating leases that were assigned to third parties. If any of these third parties fail to perform their obligations under the leases, the Company could be responsible for the lease obligation. Because of the wide dispersion among third parties and the variety of remedies available, the Company believes that if an assignee became insolvent, it would not have a material effect on the Company's financial condition, results of operations or cash flows. The Company also provides guarantees, indemnifications and assurances to others in the ordinary course of its business. Legal Proceedings The Company is subject from time to time to various claims and lawsuits, including matters involving trade, business and operational practices, personnel and employment issues, lawsuits alleging violations of state and/or federal wage and hour laws, real estate disputes, personal injury, antitrust claims, packaging or product claims, claims related to the sale of drug or pharmacy products, such as opioids, intellectual property claims and other proceedings arising in or outside of the ordinary course of business. Some of these claims or suits purport or may be determined to be class actions and/or seek substantial damages. It is the opinion of the Company's management that although the amount of liability with respect to certain of the matters described herein cannot be ascertained at this time, any resulting liability of these and other matters, including any punitive damages, will not have a material adverse effect on the Company's business or overall financial condition. The Company continually evaluates its exposure to loss contingencies arising from pending or threatened litigation and believes it has made provisions where the loss contingency is probable and can be reasonably estimated. Nonetheless, assessing and predicting the outcomes of these matters involves substantial uncertainties. While management currently believes that the aggregate estimated liabilities currently recorded are reasonable, it remains possible that differences in actual outcomes or changes in management's evaluation or predictions could arise that could be material to the Company's results of operations or cash flows. False Claims Act : Two qui tam actions alleging violations of the False Claims Act ("FCA") have been filed against the Company and its subsidiaries. Violations of the FCA are subject to treble damages and penalties of up to a specified dollar amount per false claim. In United States ex rel. Proctor v. Safeway , filed in the United States District Court for the Central District of Illinois, the relator alleges that Safeway overcharged federal government healthcare programs by not providing the federal government, as part of its usual and customary prices, the benefit of discounts given to customers in pharmacy membership discount and price-matching programs. The relator filed his complaint under seal on November 11, 2011, and the complaint was unsealed on August 26, 2015. The relator amended the complaint on March 31, 2016. On June 12, 2020, the District Court granted Safeway's motion for summary judgment, holding that the relator could not prove that Safeway acted with the intent required under the FCA, and judgment was issued on June 15, 2020. On July 10, 2020, the relator filed a motion to alter or amend the judgment and to supplement the record, which Safeway opposed. On November 13, 2020, the District Court denied relator's motion, and on December 11, 2020, relator filed a notice of appeal. The Seventh Circuit Court of Appeals affirmed the judgment in the Company's favor on April 5, 2022. On August 3, 2022, relators filed a petition seeking review by the U.S. Supreme Court. In United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al. , also filed in the Central District of Illinois, the relators allege that defendants (including various subsidiaries of the Company) overcharged federal government healthcare programs by not providing the federal government, as a part of usual and customary prices, the benefit of discounts given to customers who requested that defendants match competitor prices. The complaint was originally filed under seal and amended on November 30, 2015. On August 5, 2019, the District Court granted relators' motion for partial summary judgment, holding that price-matched prices are the usual and customary prices for those drugs. On July 1, 2020, the District Court granted the defendants' motions for summary judgment and dismissed the case, holding that the relator could not prove that defendants acted with the intent required under the FCA. Judgment was issued on July 2, 2020. On July 9, 2020, the relators filed a notice of appeal. On August 12, 2021, the Court of Appeals for the Seventh Circuit affirmed the grant of summary judgment in the Company's favor. On September 23, 2021, the relators filed a petition for rehearing en banc with the Seventh Circuit. On December 3, 2021, the Seventh Circuit denied relators' petition. On April 1, 2022, relators filed a petition seeking review by the U.S. Supreme Court. The U.S. Supreme Court decided to hear the appeals filed by the relators in Proctor and Schutte . The Supreme Court consolidated the two cases for the purpose of hearing the appeal. The Supreme Court heard oral arguments on April 18, 2023. On June 1, 2023, the Supreme Court issued an opinion adverse to the Company that reversed the lower court's rulings. On July 3, 2023, the Supreme Court issued the order remanding both cases back to the Court of Appeals for the Seventh Circuit for further review. On July 27, 2023, the Court of Appeals remanded both cases back to the U.S. District Court for the Central District of Illinois. On August 22, 2023, the District Court - as to Schutte - set a pretrial conference for March 4, 2024, and a trial date of April 29, 2024. At the same July 27 hearing, the District Court also gave the defendants leave to file motions for summary judgment on a schedule to be agreed upon. On October 11, 2023, the Company and co-defendant filed a motion for summary judgment. On the same day, the relators filed motions for partial summary judgment. Both sides' motions are pending. On February 16, 2024, the Company and co-defendant filed a motion to reconsider a prior grant of partial summary judgment against the defendants, and also a motion to continue the trial. On February 27, 2024, the District Court granted the motion to continue and vacated the April 29, 2024 trial date. At a pretrial conference on March 4, 2024, the District Court reset the trial for September 30, 2024. On May 20, 2024, the District Court heard oral argument on the pending motions. On May 22, 2024, the Company and co-defendant filed a motion to continue the trial to January 2025, but in any event no earlier than November 2024. On August 5, 2024, the District Court granted the motion to continue the trial. On September 16, 2024, the District Court set trial to begin on February 3, 2025. The District Court has not set any trial date for Proctor as of yet, and no motions are pending in that case. In both of the above cases, the federal government previously investigated the relators' allegations and declined to intervene. The relators elected to pursue their respective cases on their own and in each case have alleged FCA damages in excess of $100 million before trebling and excluding penalties. The Company is vigorously defending each of these matters. The Company has recorded an estimated liability for these matters. Pharmacy Benefit Manager (PBM) Litigation: The Company (including its subsidiary, Safeway Inc.) is a defendant in a lawsuit filed on January 21, 2021, in Minnesota state court, captioned Health Care Service Corp. et al. v. Albertsons Companies, LLC, et al. The action challenges certain prescription-drug prices reported by the Company to a pharmacy benefit manager, Prime Therapeutics LLC ("Prime"), which in turn contracted with the health-insurer plaintiffs to adjudicate and process prescription-drug reimbursement claims. On December 7, 2021, the Company filed a motion to dismiss the complaint. On January 14, 2022, the court denied the Company's motion to dismiss as to all but one count, plaintiffs' claim of negligent misrepresentation. On January 21, 2022, the Company and co-defendant SUPERVALU, Inc. ("SUPERVALU") filed a third-party complaint against Prime, asserting various claims, including: indemnification, fraud and unjust enrichment. On February 17, 2022, the Company filed in the Minnesota Court of Appeals an interlocutory appeal of the denial of their motion to dismiss on personal jurisdiction grounds (the "Jurisdictional Appeal"). On February 24, 2022, the Company and SUPERVALU filed in the trial court an unopposed motion to stay proceedings, pending the resolution of the Jurisdictional Appeal. The parties agreed on March 6, 2022, to an interim stay in the trial court pending a ruling on the unopposed motion to stay proceedings. On September 6, 2022, the Minnesota Court of Appeals denied the Jurisdictional Appeal and affirmed the trial court’s denial of the Company’s motion to dismiss. On October 6, 2022, the Company and SUPERVALU filed a petition seeking review by the Minnesota Supreme Court. On November 23, 2022, the Minnesota Supreme Court denied that petition. The Company and co-defendant SUPERVALU filed an answer to the complaint on January 23, 2023. On March 9, 2023, Prime moved to dismiss the third-party complaint filed by the Company and SUPERVALU. The court heard oral arguments on the motion on May 11, 2023. On August 9, 2023, the court denied Prime's motion as to 16 of the 17 counts in the third-party complaint, and dismissed one count without prejudice. On September 18, 2023, the Company and SUPERVALU filed an amended third-party complaint, which repleaded the one count that had been dismissed (in addition to the other claims asserted in the initial third-party complaint). On October 2, 2023, Prime filed an answer to the amended third-party complaint. The parties are presently engaged in discovery. The case is currently scheduled to be ready for trial on or after September 29, 2025. The Company is vigorously defending the claims filed against it, and the Company also intends to prosecute its claims against Prime with equal vigor. The Company has recorded an estimated liability for this matter. Opioid Litigation: The Company is one of dozens of companies that have been named as defendants in lawsuits filed by various plaintiffs, including states, counties, cities, Native American tribes, and hospitals, alleging that defendants contributed to the national opioid epidemic. At present, the Company is named in approximately 85 suits pending in various state and federal courts including the United States District Court for the Northern District of Ohio, where over 2,000 cases against various defendants have been consolidated as Multi-District Litigation ("MDL") pursuant to 28 U.S.C. §1407. All of the MDL cases naming the Company have been stayed except for three so called "bellwether" actions in Tarrant County (Texas), Town of Hull (Massachusetts) and Monterey County (California). In the Tarrant County bellwether, the Company's motion for summary judgment is pending before the Court. Discover in the two remaining bellwethers will begin shortly. The relief sought by the various plaintiffs in these matters includes compensatory damages, abatement and punitive damages as well as injunctive relief. On July 30, 2024, multiple plaintiffs filed an Omnibus Motion for Leave to Amend several of their complaints, seeking leave from the MDL court to add the Company to over 150 of additional lawsuits. The Company's response to the Omnibus Motion is due December 6, 2024. Prior to the start of a state-court trial that was scheduled for September 6, 2022, the Company reached an agreement to settle with the State of New Mexico. The New Mexico counties and municipal entities that filed 14 additional lawsuits, including Santa Fe County, agreed to the terms of the settlement. Thus, all 15 cases filed by New Mexico entities have been dismissed as a result of the settlement. The Company executed an agreement to settle three matters pending in Nevada state court. The Company recorded a liability of $21.5 million for the settlements of the cases in New Mexico and Nevada which was paid by our insurers in the fourth quarter of fiscal 2022. With respect to the remaining pending state court claims, three claims are currently proceeding through discovery, with trial dates scheduled in 2025. Those matters are pending in Dallas County (Texas), the State of Washington and the City of Philadelphia (Pennsylvania). The Company believes that it has substantial factual and legal defenses to these claims, and is vigorously defending these matters. At this stage in the proceedings, the Company is unable to determine the probability of the outcome of these remaining matters or the range of reasonably possible loss. The Company has also received, subpoenas, Civil Investigative Demands and other requests for documents and information from the U.S. Department of Justice ("DOJ") and certain state Attorneys General, and has had preliminary discussions with the DOJ with respect to purported violations of the federal Controlled Substances Act and the FCA in dispensing prescriptions. The Company has been cooperating with the government with respect to these requests for information. Other Commitments

OTHER COMPREHENSIVE INCOME OR L

OTHER COMPREHENSIVE INCOME OR LOSS	6 Months Ended
	Sep. 07, 2024
Equity [Abstract]
OTHER COMPREHENSIVE INCOME OR LOSS	OTHER COMPREHENSIVE INCOME OR LOSS Total comprehensive earnings are defined as all changes in stockholders' equity during a period, other than those from investments by or distributions to the stockholders. Generally, for the Company, total comprehensive income equals net income plus or minus adjustments for pension and other post-retirement liabilities. Total comprehensive earnings represent the activity for a period, net of tax. While total comprehensive earnings are the activity in a period and are largely driven by net earnings in that period, accumulated other comprehensive income or loss ("AOCI") represents the cumulative balance of other comprehensive income, net of tax, as of the balance sheet date. Changes in the AOCI balance by component are shown below (in millions): 28 weeks ended September 7, 2024 Total Pension and Post-retirement benefit plans Other Beginning AOCI balance $ 88.0 $ 87.5 $ 0.5 Other comprehensive income before reclassifications 3.7 — 3.7 Amounts reclassified from accumulated other comprehensive income (1) 2.5 2.5 — Tax expense (1.6) (0.6) (1.0) Current-period other comprehensive income, net of tax 4.6 1.9 2.7 Ending AOCI balance $ 92.6 $ 89.4 $ 3.2 28 weeks ended September 9, 2023 Total Pension and Post-retirement benefit plans Other Beginning AOCI balance $ 69.3 $ 71.7 $ (2.4) Other comprehensive income before reclassifications 2.8 — 2.8 Amounts reclassified from accumulated other comprehensive income (1) (3.3) (3.3) — Tax benefit (expense) 0.1 0.8 (0.7) Current-period other comprehensive (loss) income, net of tax (0.4) (2.5) 2.1 Ending AOCI balance $ 68.9 $ 69.2 $ (0.3)

NET INCOME PER CLASS A COMMON S

NET INCOME PER CLASS A COMMON SHARE	6 Months Ended
	Sep. 07, 2024
Earnings Per Share [Abstract]
NET INCOME PER CLASS A COMMON SHARE	NET INCOME PER CLASS A COMMON SHARE The Company calculates basic and diluted net income per Class A common share using the two-class method. The two-class method is an allocation formula that determines net income per Class A common share for each share of Class A common stock and Convertible Preferred Stock, a participating security, according to dividends declared and participation rights in undistributed earnings. Under this method, all earnings (distributed and undistributed) are allocated to Class A common shares and Convertible Preferred Stock based on their respective rights to receive dividends. The holders of Convertible Preferred Stock participate in cash dividends that the Company pays on its common stock to the extent that such cash dividends exceed $206.25 million per fiscal year and shares of Convertible Preferred Stock remain outstanding as of the applicable record date to participate in such dividends. As of June 17, 2023, 100% of the originally issued Convertible Preferred Stock had been converted into Class A common stock and no shares of Convertible Preferred Stock are outstanding. In applying the two-class method to interim periods, the Company allocates income to its quarterly periods independently and discretely from its year-to-date and annual periods. Basic net income per Class A common share is computed by dividing net income allocated to Class A common stockholders by the weighted average number of Class A common shares outstanding for the period, including Class A common shares to be issued with no prior remaining contingencies prior to issuance. Diluted net income per Class A common share is computed based on the weighted average number of shares of Class A common stock outstanding during each period, plus potential Class A common shares considered outstanding during the period, as long as the inclusion of such awards is not antidilutive. Potential Class A common shares consist of unvested restricted stock units ("RSUs"), restricted common stock ("RSAs") and Convertible Preferred Stock, using the more dilutive of either the two-class method or as-converted stock method. Performance-based RSUs are considered dilutive when the related performance criterion has been met. The components of basic and diluted net income per Class A common share were as follows (in millions, except per share data): 12 weeks ended 28 weeks ended September 7, September 9, September 7, September 9, Basic net income per Class A common share Net income $ 145.5 $ 266.9 $ 386.2 $ 684.1 Accrued dividends on Convertible Preferred Stock — — — (0.3) Earnings allocated to Convertible Preferred Stock — — — (0.6) Net income allocated to Class A common stockholders - Basic $ 145.5 $ 266.9 $ 386.2 $ 683.2 Weighted average Class A common shares outstanding - Basic (1) 580.1 576.0 579.5 574.7 Basic net income per Class A common share $ 0.25 $ 0.46 $ 0.67 $ 1.19 Diluted net income per Class A common share Net income allocated to Class A common stockholders - Basic $ 145.5 $ 266.9 $ 386.2 $ 683.2 Accrued dividends on Convertible Preferred Stock — — — — Earnings allocated to Convertible Preferred Stock — — — — Net income allocated to Class A common stockholders - Diluted $ 145.5 $ 266.9 $ 386.2 $ 683.2 Weighted average Class A common shares outstanding - Basic (1) 580.1 576.0 579.5 574.7 Dilutive effect of: Restricted stock units and awards 3.1 5.9 2.9 5.6 Convertible Preferred Stock (2) — — — — Weighted average Class A common shares outstanding - Diluted (3) 583.2 581.9 582.4 580.3 Diluted net income per Class A common share $ 0.25 $ 0.46 $ 0.66 $ 1.18 (1) The number of Class A common shares remaining to be issued for the 12 and 28 weeks ended September 7, 2024 and September 9, 2023 were not material. (2) Reflects the number of shares of Convertible Preferred Stock issued, if converted into common stock for the period outstanding. For the 28 weeks ended September 9, 2023, 0.6 million potential common shares outstanding related to Convertible Preferred Stock were antidilutive. (3) The number of potential Class A common shares outstanding related to RSUs and RSAs that were antidilutive for the 12 and 28 weeks ended September 7, 2024 and September 9, 2023 were not material.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		4 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Jun. 15, 2024	Jun. 17, 2023	Sep. 07, 2024	Sep. 09, 2023
Pay vs Performance Disclosure
Net income	$ 145.5	$ 266.9	$ 240.7	$ 417.2	$ 386.2	$ 684.1

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 07, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 24, 2024 is derived from the Company's annual audited Consolidated Financial Statements, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K for the fiscal year ended February 24, 2024, filed with the Securities and Exchange Commission (the "SEC") on April 22, 2024. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company'
Restricted cash	Restricted cash:
Inventories, net	Inventories, net:
Equity method investments	Equity method investments:
Segments	Segments: The Company and its subsidiaries offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company's operating divisions are geographically based, have similar economic characteristics and similar expected long-term financial performance. The Company's operating segments and reporting units are its 12 operating divisions, which are reported in one reportable segment. Each reporting unit constitutes a business for which discrete financial information is available and for which management regularly reviews the operating results. Across all operating segments, the Company operates primarily one store format. Each division offers through its stores and digital channels the same general mix of products with similar pricing to similar categories of customers, has similar distribution methods, operates in similar regulatory environments and purchases merchandise from similar or the same vendors.
Revenue recognition	Revenue recognition:
Recently issued accounting standards	Recently issued accounting standards : In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07, " Segment Reporting Topic (280): Improvements to Reportable Segment Disclosure. " The ASU improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, " Income Taxes (Topic 740): Improvements to Income Tax Disclosures. " The ASU enhances the transparency and decision usefulness of income tax disclosures and is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.
Fair Value Measurements	FAIR VALUE MEASUREMENTS The accounting guidance for fair value established a framework for measuring fair value and established a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability at the measurement date. The three levels are defined as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs in which little or no market activity exists, requiring an entity to develop its own assumptions that market participants would use to value the asset or liability. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Sep. 07, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Sales Revenue by Type of Similar Products	The following table represents Net sales and other revenue by product type (dollars in millions): 12 weeks ended 28 weeks ended September 7, September 9, September 7, September 9, Amount (1) % of Total Amount (1) % of Total Amount (1) % of Total Amount (1) % of Total Non-perishables (2) $ 9,265.0 49.9 % $ 9,236.9 50.5 % $ 21,319.0 49.8 % $ 21,323.7 50.4 % Fresh (3) 5,917.4 31.9 5,919.4 32.4 13,822.3 32.3 13,808.7 32.6 Pharmacy 2,132.0 11.5 1,741.0 9.5 4,754.8 11.1 4,041.1 9.5 Fuel 951.3 5.2 1,126.8 6.1 2,272.2 5.3 2,527.2 6.0 Other (4) 285.8 1.5 266.6 1.5 648.6 1.5 640.2 1.5 Net sales and other revenue $ 18,551.5 100.0 % $ 18,290.7 100.0 % $ 42,816.9 100.0 % $ 42,340.9 100.0 % (1) Digital related sales are included in the categories to which the revenue pertains. (2) Consists primarily of general merchandise, grocery, dairy and frozen foods. (3) Consists primarily of produce, meat, deli and prepared foods, bakery, floral and seafood. (4) Consists primarily of wholesale revenue to third parties, commissions, rental income and other miscellaneous revenue.

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Sep. 07, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents certain assets which were measured at fair value on a recurring basis as of September 7, 2024 (in millions): Fair Value Measurements Total Quoted prices in active markets Significant Significant Assets: Short-term investments (1) $ 17.2 $ 6.2 $ 11.0 $ — Non-current investments (2) 109.6 6.7 102.9 — Total $ 126.8 $ 12.9 $ 113.9 $ — Liabilities: Derivative contracts (3) $ 1.5 $ — $ 1.5 $ — Total $ 1.5 $ — $ 1.5 $ — (1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets. (2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets. (3) Primarily relates to energy derivative contracts. Included in Other current liabilities. The following table presents certain assets which were measured at fair value on a recurring basis as of February 24, 2024 (in millions): Fair Value Measurements Total Quoted prices in active markets Significant Significant Assets: Short-term investments (1) $ 23.3 $ 5.3 $ 18.0 $ — Non-current investments (2) 107.3 6.4 100.9 — Derivative contracts (3) 1.5 — 1.5 — Total $ 132.1 $ 11.7 $ 120.4 $ — Liabilities: Derivative contracts (3) $ 0.8 $ — $ 0.8 $ — Total $ 0.8 $ — $ 0.8 $ — (1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets. (2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets. (3) Primarily relates to energy derivative contracts. Included in Other assets or Other current liabilities.

LONG-TERM DEBT AND FINANCE LE_2

LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS (Tables)	6 Months Ended
	Sep. 07, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The Company's long-term debt and finance lease obligations as of September 7, 2024 and February 24, 2024, net of unamortized debt discounts of $30.8 million and $33.3 million, respectively, and deferred financing costs of $36.8 million and $42.7 million, respectively, consisted of the following (in millions): September 7, February 24, Senior Unsecured Notes due 2026 to 2030, interest rate range of 3.25% to 7.50% $ 6,512.0 $ 6,506.4 New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% 482.6 480.1 Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% 375.7 375.4 ABL Facility 50.0 200.0 Other financing obligations 29.6 29.9 Mortgage notes payable, secured 16.3 16.4 Finance lease obligations 442.2 460.4 Total debt 7,908.4 8,068.6 Less current maturities (129.1) (285.2) Long-term portion $ 7,779.3 $ 7,783.4

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	6 Months Ended
	Sep. 07, 2024
Retirement Benefits [Abstract]
Schedule of Components of Net Pension and Post-retirement Expense	The following table provides the components of net pension and post-retirement expense (income) (in millions): 12 weeks ended Pension Other post-retirement benefits September 7, September 9, September 7, September 9, Estimated return on plan assets $ (21.1) $ (22.7) $ — $ — Service cost 3.9 4.0 — — Interest cost 19.3 19.3 0.1 0.1 Amortization of prior service cost 0.1 0.1 — — Amortization of net actuarial gain (0.8) (2.4) (0.2) (0.2) Settlement loss 4.7 — — — Expense (income), net $ 6.1 $ (1.7) $ (0.1) $ (0.1) 28 weeks ended Pension Other post-retirement benefits September 7, September 9, September 7, September 9, Estimated return on plan assets $ (49.2) $ (53.0) $ — $ — Service cost 9.0 9.3 — — Interest cost 45.2 45.0 0.3 0.3 Amortization of prior service cost 0.2 0.2 — — Amortization of net actuarial gain (2.0) (3.0) (0.4) (0.5) Settlement loss 4.7 — — — Expense (income), net $ 7.9 $ (1.5) $ (0.1) $ (0.2)

OTHER COMPREHENSIVE INCOME OR_2

OTHER COMPREHENSIVE INCOME OR LOSS (Tables)	6 Months Ended
	Sep. 07, 2024
Equity [Abstract]
Schedule of Changes In the Accumulated Other Comprehensive Income or Loss	Changes in the AOCI balance by component are shown below (in millions): 28 weeks ended September 7, 2024 Total Pension and Post-retirement benefit plans Other Beginning AOCI balance $ 88.0 $ 87.5 $ 0.5 Other comprehensive income before reclassifications 3.7 — 3.7 Amounts reclassified from accumulated other comprehensive income (1) 2.5 2.5 — Tax expense (1.6) (0.6) (1.0) Current-period other comprehensive income, net of tax 4.6 1.9 2.7 Ending AOCI balance $ 92.6 $ 89.4 $ 3.2 28 weeks ended September 9, 2023 Total Pension and Post-retirement benefit plans Other Beginning AOCI balance $ 69.3 $ 71.7 $ (2.4) Other comprehensive income before reclassifications 2.8 — 2.8 Amounts reclassified from accumulated other comprehensive income (1) (3.3) (3.3) — Tax benefit (expense) 0.1 0.8 (0.7) Current-period other comprehensive (loss) income, net of tax (0.4) (2.5) 2.1 Ending AOCI balance $ 68.9 $ 69.2 $ (0.3)

NET INCOME PER CLASS A COMMON_2

NET INCOME PER CLASS A COMMON SHARE (Tables)	6 Months Ended
	Sep. 07, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The components of basic and diluted net income per Class A common share were as follows (in millions, except per share data): 12 weeks ended 28 weeks ended September 7, September 9, September 7, September 9, Basic net income per Class A common share Net income $ 145.5 $ 266.9 $ 386.2 $ 684.1 Accrued dividends on Convertible Preferred Stock — — — (0.3) Earnings allocated to Convertible Preferred Stock — — — (0.6) Net income allocated to Class A common stockholders - Basic $ 145.5 $ 266.9 $ 386.2 $ 683.2 Weighted average Class A common shares outstanding - Basic (1) 580.1 576.0 579.5 574.7 Basic net income per Class A common share $ 0.25 $ 0.46 $ 0.67 $ 1.19 Diluted net income per Class A common share Net income allocated to Class A common stockholders - Basic $ 145.5 $ 266.9 $ 386.2 $ 683.2 Accrued dividends on Convertible Preferred Stock — — — — Earnings allocated to Convertible Preferred Stock — — — — Net income allocated to Class A common stockholders - Diluted $ 145.5 $ 266.9 $ 386.2 $ 683.2 Weighted average Class A common shares outstanding - Basic (1) 580.1 576.0 579.5 574.7 Dilutive effect of: Restricted stock units and awards 3.1 5.9 2.9 5.6 Convertible Preferred Stock (2) — — — — Weighted average Class A common shares outstanding - Diluted (3) 583.2 581.9 582.4 580.3 Diluted net income per Class A common share $ 0.25 $ 0.46 $ 0.66 $ 1.18 (1) The number of Class A common shares remaining to be issued for the 12 and 28 weeks ended September 7, 2024 and September 9, 2023 were not material. (2) Reflects the number of shares of Convertible Preferred Stock issued, if converted into common stock for the period outstanding. For the 28 weeks ended September 9, 2023, 0.6 million potential common shares outstanding related to Convertible Preferred Stock were antidilutive. (3) The number of potential Class A common shares outstanding related to RSUs and RSAs that were antidilutive for the 12 and 28 weeks ended September 7, 2024 and September 9, 2023 were not material.

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ / shares in Units, $ in Millions	3 Months Ended		4 Months Ended	6 Months Ended
	Sep. 07, 2024 USD ($) format $ / shares shares	Sep. 09, 2023 USD ($)	Jun. 17, 2023 USD ($)	Sep. 07, 2024 USD ($) division segment format $ / shares shares	Sep. 09, 2023 USD ($)	Feb. 24, 2024 USD ($) $ / shares shares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Restricted cash	$ 4.2			$ 4.2		$ 4.5
LIFO expense	4.8	$ 26.2		19.4	$ 60.2
Income tax expense	$ 41	$ 67.5		$ 110.2	$ 133.6
Effective tax rate	22%	20.20%		22.20%	16.30%
Reduction of reserve			$ 49.7
Number of divisions | division				12
Number of reportable segments | segment				1
Number of store format | format	1			1
Receivables, net	$ 897.6			$ 897.6		724.4
Contract liability related to gift cards	97.3			97.3		111.4
Pharmacy
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables, net	$ 490.4			$ 490.4		$ 376.1
Class A-1 convertible common stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock, shares authorized (in shares) | shares	150,000,000			150,000,000		150,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.01			$ 0.01		$ 0.01
Common stock shares issued (in shares) | shares	0			0		0
Convertible Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Preferred stock, shares authorized (in shares) | shares	100,000,000			100,000,000		100,000,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.01			$ 0.01		$ 0.01
Series A Convertible Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Preferred stock, shares authorized (in shares) | shares	1,750,000			1,750,000		1,750,000
Series A-1 Convertible Preferred Stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Preferred stock, shares authorized (in shares) | shares	1,410,000			1,410,000		1,410,000
Undesignated preferred stock
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Preferred stock, shares issued (in shares) | shares	0			0		0
EI Rancho
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Proceeds from sale of equity method investments			166.1
Income from equity method investments			$ 10.5
EI Rancho
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership interest percentage			45%

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,551.5	$ 18,290.7	$ 42,816.9	$ 42,340.9
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,551.5	$ 18,290.7	$ 42,816.9	$ 42,340.9
Percentage of total net sales and other revenue	100%	100%	100%	100%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,265	$ 9,236.9	$ 21,319	$ 21,323.7
Percentage of total net sales and other revenue	49.90%	50.50%	49.80%	50.40%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,917.4	$ 5,919.4	$ 13,822.3	$ 13,808.7
Percentage of total net sales and other revenue	31.90%	32.40%	32.30%	32.60%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 2,132	$ 1,741	$ 4,754.8	$ 4,041.1
Percentage of total net sales and other revenue	11.50%	9.50%	11.10%	9.50%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 951.3	$ 1,126.8	$ 2,272.2	$ 2,527.2
Percentage of total net sales and other revenue	5.20%	6.10%	5.30%	6%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 285.8	$ 266.6	$ 648.6	$ 640.2
Percentage of total net sales and other revenue	1.50%	1.50%	1.50%	1.50%

MERGER AGREEMENT (Details)

MERGER AGREEMENT (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended			4 Months Ended
	Oct. 13, 2022	Sep. 07, 2024	Sep. 09, 2023	Dec. 03, 2022	Jun. 15, 2024	Jun. 17, 2023
Business Acquisition [Line Items]
Dividends declared (in dollars per share)		$ 0.12	$ 0.12		$ 0.12	$ 0.12
Merger Agreement
Business Acquisition [Line Items]
Conversion price, right to receive (in dollars per share)	$ 34.10
Special dividend, average closing price of shares, term	5 days
Termination fee obligation	$ 600
Merger Agreement | Class A Common Stock
Business Acquisition [Line Items]
Dividends declared (in dollars per share)				$ 6.85

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Millions	Sep. 07, 2024	Feb. 24, 2024
Liabilities:
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Recurring
Assets:
Short-term investments	$ 17.2	$ 23.3
Non-current investments	109.6	107.3
Derivative contracts		1.5
Total	126.8	132.1
Liabilities:
Derivative Liability	1.5	0.8
Total	1.5	0.8
Recurring | Quoted prices in active markets for identical assets (Level 1)
Assets:
Short-term investments	6.2	5.3
Non-current investments	6.7	6.4
Derivative contracts		0
Total	12.9	11.7
Liabilities:
Derivative Liability	0	0
Total	0	0
Recurring | Significant observable inputs (Level 2)
Assets:
Short-term investments	11	18
Non-current investments	102.9	100.9
Derivative contracts		1.5
Total	113.9	120.4
Liabilities:
Derivative Liability	1.5	0.8
Total	1.5	0.8
Recurring | Significant unobservable inputs (Level 3)
Assets:
Short-term investments	0	0
Non-current investments	0	0
Derivative contracts		0
Total	0	0
Liabilities:
Derivative Liability	0	0
Total	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 07, 2024	Feb. 24, 2024
Micro-Fulfillment Centers
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Impairment loss	$ 39.8
Retail Stores
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Impairment loss	13.5
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total debt amount	7,411.9	$ 7,457.2
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total debt amount	$ 7,533.8	$ 7,684.2

LONG-TERM DEBT AND FINANCE LE_3

LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Sep. 07, 2024	Feb. 24, 2024
Debt Instrument [Line Items]
Unamortized debt discounts	$ 30.8	$ 33.3
Deferred financing costs	36.8	42.7
ABL Facility | Line of Credit
Debt Instrument [Line Items]
Outstanding balance on line of credit	50	200
Repayments of lines of credit	200
Proceeds from lines of credit	50
Outstanding balance on letters of credit	$ 41.7	$ 48.3

LONG-TERM DEBT AND FINANCE LE_4

LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	Sep. 07, 2024	Feb. 24, 2024
Debt Instrument [Line Items]
Finance lease obligations	$ 442.2	$ 460.4
Total debt	7,908.4	8,068.6
Less current maturities	(129.1)	(285.2)
Long-term portion	7,779.3	7,783.4
Senior Unsecured Notes due 2026 to 2030, interest rate range of 3.25% to 7.50% | Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	$ 6,512	6,506.4
Senior Unsecured Notes due 2026 to 2030, interest rate range of 3.25% to 7.50% | Senior Notes | Minimum
Debt Instrument [Line Items]
Stated interest rate percentage	3.25%
Senior Unsecured Notes due 2026 to 2030, interest rate range of 3.25% to 7.50% | Senior Notes | Maximum
Debt Instrument [Line Items]
Stated interest rate percentage	7.50%
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable
Debt Instrument [Line Items]
Long-term debt, gross	$ 482.6	480.1
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable | Minimum
Debt Instrument [Line Items]
Stated interest rate percentage	6.52%
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable | Maximum
Debt Instrument [Line Items]
Stated interest rate percentage	8.70%
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable
Debt Instrument [Line Items]
Long-term debt, gross	$ 375.7	375.4
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable | Minimum
Debt Instrument [Line Items]
Stated interest rate percentage	7.25%
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable | Maximum
Debt Instrument [Line Items]
Stated interest rate percentage	7.45%
ABL Facility | Line of Credit
Debt Instrument [Line Items]
Long-term debt, gross	$ 50	200
Other financing obligations
Debt Instrument [Line Items]
Long-term debt, gross	29.6	29.9
Mortgage notes payable, secured | Mortgage Notes Payable
Debt Instrument [Line Items]
Long-term debt, gross	$ 16.3	$ 16.4

EMPLOYEE BENEFIT PLANS - Schedu

EMPLOYEE BENEFIT PLANS - Schedule of Components of Net Pension and Post-Retirement Expense (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Pension
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Estimated return on plan assets	$ (21.1)	$ (22.7)	$ (49.2)	$ (53)
Service cost	3.9	4	9	9.3
Interest cost	19.3	19.3	45.2	45
Amortization of prior service cost	0.1	0.1	0.2	0.2
Amortization of net actuarial gain	(0.8)	(2.4)	(2)	(3)
Settlement loss	4.7	0	4.7	0
Expense (income), net	6.1	(1.7)	7.9	(1.5)
Other post-retirement benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Estimated return on plan assets	0	0	0	0
Service cost	0	0	0	0
Interest cost	0.1	0.1	0.3	0.3
Amortization of prior service cost	0	0	0	0
Amortization of net actuarial gain	(0.2)	(0.2)	(0.4)	(0.5)
Settlement loss	0	0	0	0
Expense (income), net	$ (0.1)	$ (0.1)	$ (0.1)	$ (0.2)

EMPLOYEE BENEFIT PLANS - Narrat

EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
Retirement Benefits [Abstract]
Contribution made to defined benefit plan	$ 24.4	$ 3.9	$ 37.1	$ 10.4
Expected future employer contributions for remainder of the fiscal year	$ 50.3		$ 50.3

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS (Details) $ in Millions			6 Months Ended
	Jul. 30, 2024 lawsuit	Sep. 06, 2022 lawsuit case claim	Sep. 07, 2024 USD ($) lawsuit claim case	Aug. 09, 2023 count	Apr. 18, 2023 case	Feb. 25, 2023 USD ($)
Qui Tam Lawsuits | Pending Litigation
Loss Contingencies [Line Items]
Number of lawsuits filed against the company			2
Qui Tam Lawsuits | Pending Litigation | Minimum
Loss Contingencies [Line Items]
Loss contingency, amount of damages sought (in excess of) | $			$ 100
United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al. | Pending Litigation
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | case					2
Pharmacy Benefit Manager (PBM) Litigation | Pending Litigation
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | count				17
Consolidated Cases for Multidistrict Litigation
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | claim		3	3
Claims settled | case		15
Liability for settlements | $						$ 21.5
Consolidated Cases for Multidistrict Litigation | New Mexico Counties
Loss Contingencies [Line Items]
Additional claims		14
Consolidated Cases for Multidistrict Litigation | Threatened Litigation
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | case			2,000
Additional claims	150
Consolidated Cases for Multidistrict Litigation | Threatened Litigation | Blackfeet Tribe
Loss Contingencies [Line Items]
Number of new claims filed			85
Consolidated Cases for Multidistrict Litigation | Threatened Litigation | Tarrant County (Texas), Town of Hull (Massachusetts) and Monterey County (California)
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | claim			3
Consolidated Cases for Multidistrict Litigation | Threatened Litigation | Town of Hull (Massachusetts) and Monterey County (California)
Loss Contingencies [Line Items]
Number of lawsuits filed against the company | claim			2

OTHER COMPREHENSIVE INCOME OR_3

OTHER COMPREHENSIVE INCOME OR LOSS (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Sep. 07, 2024	Sep. 09, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,913.1	$ 2,000	$ 2,747.5	$ 1,610.7
Other comprehensive income before reclassifications			3.7	2.8
Amounts reclassified from accumulated other comprehensive income			2.5	(3.3)
Tax benefit (expense)			(1.6)	0.1
Other comprehensive income (loss)	5.9	(1.5)	4.6	(0.4)
Ending balance	3,020.3	2,216.6	3,020.3	2,216.6
Accumulated other comprehensive income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	86.7	70.4	88	69.3
Ending balance	92.6	68.9	92.6	68.9
Pension and Post-retirement benefit plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			87.5	71.7
Other comprehensive income before reclassifications			0	0
Amounts reclassified from accumulated other comprehensive income			2.5	(3.3)
Tax benefit (expense)			(0.6)	0.8
Other comprehensive income (loss)			1.9	(2.5)
Ending balance	89.4	69.2	89.4	69.2
Other
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			0.5	(2.4)
Other comprehensive income before reclassifications			3.7	2.8
Amounts reclassified from accumulated other comprehensive income			0	0
Tax benefit (expense)			(1)	(0.7)
Other comprehensive income (loss)			2.7	2.1
Ending balance	$ 3.2	$ (0.3)	$ 3.2	$ (0.3)

NET INCOME PER CLASS A COMMON_3

NET INCOME PER CLASS A COMMON SHARE - Narrative (Details) - USD ($) $ in Thousands		6 Months Ended
	Jun. 17, 2023	Sep. 07, 2024
Series A-1 Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Preferred stock participation in cash dividends over dividends to common stock		$ 206,250
Series A Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Convertible temporary equity, outstanding, percentage	100%
Temporary equity, shares outstanding (in shares)	0

NET INCOME PER CLASS A COMMON_4

NET INCOME PER CLASS A COMMON SHARE - Schedule of Components of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		4 Months Ended		6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023	Jun. 15, 2024	Jun. 17, 2023	Sep. 07, 2024	Sep. 09, 2023
Basic net income per Class A common share
Net income	$ 145.5	$ 266.9	$ 240.7	$ 417.2	$ 386.2	$ 684.1
Accrued dividends on Convertible Preferred Stock	0	0			0	(0.3)
Earnings allocated to Convertible Preferred Stock	0	0			0	(0.6)
Net income allocated to Class A common stockholders - Basic	$ 145.5	$ 266.9			$ 386.2	$ 683.2
Weighted average Class A common shares outstanding - Basic (in shares)	580.1	576			579.5	574.7
Basic net income per Class A common share (in dollars per share)	$ 0.25	$ 0.46			$ 0.67	$ 1.19
Diluted net income per Class A common share
Net income allocated to Class A common stockholders - Basic	$ 145.5	$ 266.9			$ 386.2	$ 683.2
Accrued dividends on Convertible Preferred Stock	0	0			0	0
Earnings allocated to Convertible Preferred Stock	0	0			0	0
Net income allocated to Class A common stockholders - Diluted	$ 145.5	$ 266.9			$ 386.2	$ 683.2
Dilutive effect of:
Convertible Preferred Stock (in shares)	0	0			0	0
Weighted average Class A common shares outstanding - Diluted (in shares)	583.2	581.9			582.4	580.3
Diluted net income per Class A common share (in dollars per share)	$ 0.25	$ 0.46			$ 0.66	$ 1.18
Restricted stock units and awards
Dilutive effect of:
Restricted stock units and awards (in shares)	3.1	5.9			2.9	5.6
Series A-1 Convertible Preferred Stock
Dilutive effect of:
Convertible Preferred Stock (in shares)						0.6